Our Accomplishments The University of Rochester Medical Center was one of the first 12 to receive a $40 million Clinical Translational Science Award from the National Institutes of Health. The University is among the top 10 institutions in the country in royalty revenues from licensed technologies. In the past 10 years, more than 20 new companies have been formed with URMC technologies. James P. Wilmot Cancer Center is home to the radiation oncology experts who were the first to take new, life-saving brain cancer treatment—shaped-beam radiosurgery—and apply it to other patients suffering from cancer that’s spread to the lungs and other organs. This is a natural progression for the medical center, because early radiation work at UR formed the foundation for the field of Radiation Oncology. A vaccine that our scientists created against Haemophilus influenza type b (Hib) has virtually wiped out a leading cause of meningitis in preschoolers. Scientists then used the same approach to create a vaccine that prevents infection by pneumococcal bacteria, which cause meningitis, ear infections, pneumonia, and other maladies. University cardiologists have revolutionized the treatment of heart disease worldwide by showing that an implantable cardiac defibrillator significantly reduces death rates in certain groups of patients. The University of Rochester Medical Center was the first in the nation to implant an investigational medical device that lowers blood pressure by activating the body’s natural blood pressure regulation systems. The University’s James P. Wilmot Cancer Center is home to the nation’s leading program aimed at helping cancer patients cope with the side effects of cancer treatment. Strong Memorial Hospital was among the first 2 percent of U.S. hospitals to be recognized as a Nursing Magnet Hospital, an international quality nursing designation. Golisano Children’s Hospital is one of only three sites nationwide selected by the Centers for Disease Control to help evaluate new vaccines and to set the timetable for future vaccines. Our scientists have brought about a quality of human vision previously thought impossible, by discovering previously unknown aberrations in the human eye and developing new ways to correct for those imperfections. University research laid the groundwork for the radiation treatment of human cancers, which is now used in more than 80 percent of cancer cases. Our researchers were first to administer lung surfactant to premature infants, dramatically improving their survival rates. Surfactants are now used around the world. The University plays a leading role in the nation’s effort fighting AIDS. Nearly every one of the drugs now available to treat AIDS has been tested in Rochester.